Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism

Abstract excerpt

The genetic alterations that cause the development of glucocorticoid and/or mineralocorticoid producing benign adrenocortical tumors and hyperplasias have largely been elucidated over the past two decades through advances in genomics. In benign aldosterone-producing adrenocortical tumors and hyperplasias, alteration of intracellular calcium signaling has been found to be significant in aldosterone hypersecretion,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adrenal and Paraganglionic Tumors
• Share to Cardiac tumors and thrombi
• Share to Hormonal Regulation and Hypertension